Loading clinical trials...
Loading clinical trials...
A Combination of AKR1B10 and CA19-9 Improves the Diagnosis of Pancreatic Ductal Adenocarcinoma：A Multicenter Study
Conditions
Locations
3
China
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
Changhai Hospital of Shanghai
Shanghai, China
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, China
Start Date
February 1, 2021
Primary Completion Date
December 31, 2021
Completion Date
February 1, 2022
Last Updated
October 16, 2024
NCT04657068
NCT06445062
NCT04900818
NCT07432633
NCT04851119
NCT06005493
Lead Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions